Stockhub

Intech Biopharm Corporation: Revision history

View logs for this page

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

28 September 2022

  • curprev 00:3800:38, 28 September 2022 87.224.91.72 talk 633 bytes +633 Created page with "== Summary<ref>Source: Yahoo Finance.</ref> == Intech Biopharm Corporation focuses on developing and manufacturing generic drugs to treat respiratory diseases. It owns iLEF (inhaled low ethanol formulation), a metered dose inhaler platform for treating asthma and chronic pulmonary obstructive disease; and dry powder inhaler, a product comprises of blisters and capsules. The company offers its products under the SYN006, SYN010, SYN007, Synflutide, Duasma, Synvent, and SY..."
Retrieved from "https://stockhub.co/research/Intech_Biopharm_Corporation"